April 23, 2020 / 11:48 AM / a month ago

BRIEF-Novus Therapeutics Says Nasdaq Has Determined To Toll Compliance Period For Minimum Bid Price Requirement Through June 30 For Co

April 23 (Reuters) - Novus Therapeutics Inc:

* NOVUS THERAPEUTICS INC - GOT NOTICE THAT NASDAQ HAS DETERMINED TO TOLL COMPLIANCE PERIOD FOR MINIMUM BID PRICE REQUIREMENT THROUGH JUNE 30 FOR CO Source text: bit.ly/2XZ0BHK Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below